Ventas Inc

Welltower posted its 15th consecutive quarter of net operating income growth above 20% while Ventas doubled its investment target to $4.5 billion, as two million people turn 80 in 2026 against record-low new senior housing starts. Ventas raised full-year 2026 guidance to Normalized FFO per share of $3.85 to $3.90, an 8% to 10% increase, and lifted its investment target to $4.5B from $3B, focused on senior housing, after SHOP same-store cash NOI grew 16.3% year over year. Welltower, the largest of the three at a roughly $169.7 billion market cap, grew SHO same-store NOI 20.5% with occupancy at 89.4%, raised 2026 guidance to $6.36 to $6.44 per diluted share, and declared a quarterly dividend of 85 cents, a 15% increase and its 221st consecutive quarterly dividend. Omega Healthcare, a triple-net skilled nursing landlord with an emerging RIDEA segment, raised full-year 2026 AFFO guidance to $3.22 to $3.26 per diluted share and lifted its quarterly dividend by a penny to 68 cents, though tenant Genesis Healthcare has been in Chapter 11 since July 2025 with $148.5 million in loans outstanding. Ventas and Welltower capture net operating income directly through RIDEA-structured senior housing operating portfolios, while Omega takes tenant credit and reimbursement risk instead of operating risk.

Ventas, Inc. has declared a quarterly dividend of $0.52 per common share. The Chicago-based real estate investment trust said its Board of Directors approved the payout, which will be paid in cash on October 15, 2026, to stockholders of record as of the close of business on September 30, 2026. Ventas is an S&P 500 company with approximately 1,450 properties in North America and the United Kingdom, including more than 900 senior housing communities, along with outpatient medical buildings, research centers and healthcare facilities.

Ventas reported record total company same-store cash net operating income growth of 10% year-over-year in the second quarter of 2026, driven by an 18% surge in its US senior housing operating portfolio. Normalized funds from operations per share reached $0.97, a 9% increase, prompting the company to raise its full-year 2026 normalized FFO per share guidance to a range of $3.85 to $3.90, representing 8% to 10% growth. The company also lifted its 2026 investment guidance to $4.5 billion, up from $3 billion, with a focus on senior housing, having already completed over $3 billion in investments year-to-date across 27 transactions at an average expected first-year yield of 6.6%. Net debt to EBITDA improved to 4.7 times, the best leverage level in over a decade, while US senior housing operating portfolio same-store occupancy expanded by 360 basis points and net operating income margin reached 31%, up 210 basis points.

Analysts have raised the Zacks Consensus Estimate for Ventas' 2026 funds from operations per share by 2 cents over the past two months to $3.87, reflecting optimism about the healthcare REIT's senior housing business. The company's Senior Housing Operating Portfolio, which accounted for 56% of annualized net operating income in the first quarter of 2026, saw same-store cash NOI jump more than 15% year over year, driven by nearly 9% revenue growth and a 170-basis-point improvement in NOI margins. Management raised its 2026 SHOP same-store cash NOI growth outlook to 15-17%, supported by limited new construction and rising demand from an aging population. Ventas also expanded through acquisitions, investing approximately $1.7 billion in senior housing communities year-to-date through April 27, 2026, and increasing its full-year investment target to $3 billion. However, the company faces headwinds from intense competition, tenant concentration risk with top tenants Ardent and Kindred contributing 6% and 5.2% of NOI respectively, and high debt levels with total debt of about $12.5 billion and expected 2026 interest expenses of around $640 million. Shares of Ventas have gained 4.5% over the past three months, underperforming the industry's 11.5% growth.

Ventas has named Andrew L. Wattula Executive Vice President of Outpatient Medical & Research and CEO of its wholly-owned subsidiary Lillibridge Healthcare Services, effective August 2026. He succeeds Peter J. Bulgarelli, who retired in May 2026, and will oversee the company's outpatient medical and research business, a leading owner and manager of properties at the intersection of medicine, research, and universities. Wattula most recently served as Chief Operating Officer at Hudson Pacific Properties, where he led operations for a 16.5 million square foot office and retail portfolio, and previously held roles at Beacon Capital Partners and Hines. He will report to Ventas Chairman and CEO Debra A. Cafaro.